Jonathan Milner
Investor profile
Angel
Also recorded as: Jonathan Milner.
Deals
13
distinct rounds
Companies
10
backed
Active span
2017–2026
10 yrs
Total round €
€231M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- o2h Ventures4
- Cambridge Enterprise2
- Elevage Medical Technologies2
- GK Goh2
- Khosla Ventures2
- Magnetic Ventures2
- Martlet Capital2
- Octopus Ventures2
- Verve Ventures2
- 24Haymarket1
- ACF investors1
- Amadeus Capital Partners1
- Ananda Ventures1
- ARK Invest1
- Arrowfield Capital1
- Astellas Venture Management1
- BGF1
- BioCity1
- BRAIN Biotech1
- British Business Bank1
- Bruce Barclay1
- Cambridge Angels1
- Cambridge Innovation Capital1
- Capital1
- Cheshire Life Science Fund1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Nuclera | UK | 3 | €94M |
| Relation Therapeutics | UK | 2 | €56M |
| PhoreMost | UK | 1 | €39M |
| SolasCure | UK | 1 | €12M |
| NanoSyrinx | UK | 1 | €7.2M |
| PharmEnable | UK | 1 | €6.9M |
| Pencil Biosciences | UK | 1 | €6.5M |
| Clustermarket | UK | 1 | €2.9M |
| Spirea | UK | 1 | €2.9M |
| Repositive | UK | 1 | €2.8M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Nuclera | Series A | €69M | 2024-10 |
| PhoreMost | Series B | €39M | 2024-09 |
| Relation Therapeutics | Seed | €32M | 2024-03 |
| Relation Therapeutics | Seed | €24M | 2022-06 |
| Nuclera | Series B | €15M | 2022-07 |
| SolasCure | Series B | €12M | 2023-03 |
| Nuclera | Series C | €10M | 2026-01 |
| NanoSyrinx | Seed | €7.2M | 2021-07 |
| PharmEnable | Seed | €6.9M | 2023-05 |
| Pencil Biosciences | Seed | €6.5M | 2023-09 |